| |
|
|
|
Avadel Pharmaceuticals plc  
|
|
7.96 -0.1 (-0.01%) |
05-28 16:00 |
|
Open: |
8.07 |
Pre close: |
8.06 |
Target:
|
13.04
|
|
High: |
8.265 |
Low: |
7.88 |
Resistance:
|
11.17
13.49
|
|
Volume: |
510,924 |
Market Cap: |
463M |
Support:
|
7.41
6.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
8.33
 |
MACD |
MACD(12,26):
|
-0.29 |
|
MA(20): |
8.67 |
Signal(12,26,9): |
-0.22 |
|
MA(100): |
8.23  |
Stochastic Oscillator |
%K(14,3):
|
30.67 |
|
MA(250): |
5.55 |
%D(3): |
38.37 |
|
Average Volume(K) |
3-Month: |
90190
|
52-Week |
High:
|
13.49 |
|
10-Days: |
67256 |
Low: |
1.53 |
|
RSI |
RSI(14):
|
42.07 |
Change(%): |
368.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
-187.4 |
Shares Out. (M) |
58.13 |
|
EPS Est. Current Year |
1.160 |
Return on Assets (ttm) |
-5.2 |
Shares Float (M) |
43.32 |
|
EPS Est. Next Year |
0.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
8.13 |
|
EPS Est. Next Quarter |
-0.100 |
Qtrly Rev. Growth |
-25.5 |
% Held by Institutions |
39.87 |
|
Forward EPS |
-0.890 |
Gross Profit (p.s.) |
0.810 |
Shares Short (K) |
6590 |
|
Book Value (p.s.) |
0.690 |
EBITDA (p.s.) |
-0.229 |
P/E |
-14.47 |
|
Sales Per Share |
0.946 |
Qtrly Earnings Growth |
0.00 |
P/BV |
11.54 |
|
Profit Margin |
-38.30 |
Operating Cash Flow
(M) |
-28.75 |
P/S |
8.41 |
|
Operating Margin |
-28.86 |
Levered Free Cash Flow
(M) |
-1.65 |
P/CF |
-16.09 |
|
|
|
|
|
|
